R-p Mycin
Drug - R-p Mycin
The trade name of the product as shown on the labeling.
Dosage -
TABLET, DELAYED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Erythromycin
Multiple ingredients are in alphabetical order.
Strength -
250MG
The potency of the active ingredient(s), Erythromycin. May repeat for multiple part products.
Applicant -
SOLVAY
The firm name holding legal responsibility for R-p Mycin. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
061659
The FDA assigned number to R-p Mycin. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify R-p Mycin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Approved Prior to Jan 1, 1982
The date R-p Mycin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of R-p Mycin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs R-p Mycin is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Solvay Pharmaceuticals
The full name of the firm holding legal responsibility for the new application of R-p Mycin.
R-p Mycin
Ilotycin 250mg Tablet, Delayed Release; Oral Robimycin 250mg Tablet, Delayed Release; Oral R-p Mycin 250mg Tablet, Delayed Release; Oral E-base 333mg Tablet, Delayed Release; Oral E-base 500mg Tablet, Delayed Release; Oral E-mycin 250mg Tablet, Delayed Release; Oral E-mycin 333mg Tablet, Delayed Release; Oral Ery-tab 250mg Tablet, Delayed Release; Oral Ery-tab 333mg Tablet, Delayed Release; Oral Ery-tab 500mg Tablet, Delayed Release; Oral
NewDrugInformation
|